(VIANEWS) – Shares of 10x Genomics (NASDAQ: TXG) jumped 5.42% to $94.50 at 10:43 EST on Thursday, after five consecutive sessions in a row of losses. NASDAQ is jumping 1.4% to $14,540.72, after two sequential sessions in a row of losses. This seems, up until now, an all-around up trend exchanging session today.

10x Genomics’s last close was $89.64, 57.11% under its 52-week high of $208.99.


Today’s last reported volume for 10x Genomics is 139553 which is 82.24% below its average volume of 786140.

10x Genomics’s Sales

10x Genomics’s sales growth is 78.1% for the present quarter and 33.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 70.8% and 97.2%, respectively.

10x Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.


10x Genomics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.50%, a negative 2.25%, and a positive 3.22%, respectively.

10x Genomics’s highest amplitude of average volatility was 6.50% (last week), 3.24% (last month), and 3.22% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

10x Genomics’s stock is considered to be overbought (>=80).

10x Genomics’s Stock Yearly Top and Bottom Value

10x Genomics’s stock is valued at $94.50 at 10:43 EST, way under its 52-week low of $128.15.

10x Genomics’s Moving Average

10x Genomics’s value is way below its 50-day moving average of $155.93 and way under its 200-day moving average of $170.12.

More news about 10x Genomics (TXG).


Please enter your comment!
Please enter your name here